Alan Cantor
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 21
- Oncology top 0.5%
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 21
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders 15
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 20
-
- Lung Cancer Treatments and Mutations 20
-
- Neuroblastoma Research and Treatments 17
-
- RNA modifications and cancer 16
- Epigenetics and DNA Methylation 16
- Co-authors
- Stuart H. OrkinGerold BeplerYuko FujiwaraGeorge R. SimonCharles E. CoxRichard JoveSwati SharmaJonghwan Kim
- Cited by
- Cancer ResearchOncologyHematology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Alan Cantor
281 papers receiving 17.3k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Cancer Research 2.9k
- Oncology 4.6k
- Hematology 1.6k
- Genetics 1.5k
- Pathology and Forensic Medicine 2.1k
Countries citing papers authored by Alan Cantor
This map shows the geographic impact of Alan Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Cantor more than expected).
Fields of papers citing papers by Alan Cantor
This network shows the impact of papers produced by Alan Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Cantor. The network helps show where Alan Cantor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Cantor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 16 | |
| 7 | 2018 | 58 | |
| 8 | 2013 | 152 | |
| 9 | 2012 | 160 | |
| 10 | 2010 | 25 | |
| 11 | Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11Abreakdown → | 2008 | 668 |
| 12 | 2008 | 56 | |
| 13 | 2007 | 147 | |
| 14 | 2003 | 108 | |
| 15 | SAS survival analysis techniques for medical research | 2003 | 53 |
| 16 | 2003 | 6 | |
| 17 | 2002 | 77 | |
| 18 | 1997 | 13 | |
| 19 | 1997 | 115 | |
| 20 | 1993 | 24 |
About Alan Cantor
Alan Cantor is a scholar working on Genetics, Hematology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 286 papers that have together received 17.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Breast Cancer Treatment Studies (21 papers), Breast Lesions and Carcinomas (20 papers), Lung Cancer Treatments and Mutations (20 papers), Neuroblastoma Research and Treatments (17 papers), RNA modifications and cancer (16 papers), Epigenetics and DNA Methylation (16 papers) and Hemoglobinopathies and Related Disorders (15 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (4.6k citations), Hematology (1.6k citations), Genetics (1.5k citations) and Pathology and Forensic Medicine (2.1k citations). Alan Cantor has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Stuart H. Orkin, Gerold Bepler, Yuko Fujiwara, George R. Simon, Charles E. Cox, Richard Jove, Swati Sharma, Jonghwan Kim, Garrett M. Brodeur and Thomas E. Akie. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Lung Cancer and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.